N 1/2020

(To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

,

Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Udyog Bhawan New Delhi

Notification No. 01/2015-2020 New Delhi, Dated: 4” April 2020

Subject: - Amendment in Export Policy of Hydroxychloroquine.

-§.0. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy,.2015-20, the Central Government hereby makes the following amendments in Notification No. 54 dated 25.03.2020 related to export of Hydroxychloroquine and its formulations, with immediate effect:

“ The Para 2 in the notification allowing export of Hydroxychloroquine and its formulations in certain conditions specified under it , stands deleted”

2. Effect of this Notification:

The export of Hydroxychloroquine and formulations made _ from Hydroxychloroquine falling under any ITCHS Code, including the ITCHS Codes mentioned in the Notification No. 54 dated 25.3.2020 is no longer allowed from SEZs/EOUs or against Advance Authorisation or under the Para 1.05(b) of Foreign Trade Policy 2015-20 or against full advance payment as specified in Para 2 of the Notification. The export of Hydroxychloroquine and formulations made from Hydroxychloroquine, therefore, shall remain prohibited, without any exception.

(Amit Yuen Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India E-mail: dgft@nic.in

(Issued from file No. 01/91/180/21/AM20/EC)

.